Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ultra-low-dose Chest CT for HHT
Sponsor: Mayo Clinic
Summary
This study aims to develop a novel ultra-low dose chest CT technology for use in Hereditary Hemorrhagic Teleangiectasia (HHT) patients and to determine the lowest possible radiation dose that is achievable without sacrificing the diagnostic quality.
Official title: Novel Ultra-low-dose Chest CT Technique to Screen for Pulmonary Arteriovenous Malformations in Pediatric Patients With Hereditary Hemorrhagic Teleangiectasia
Key Details
Gender
All
Age Range
1 Year - 17 Years
Study Type
OBSERVATIONAL
Enrollment
10
Start Date
2021-04-21
Completion Date
2025-12-31
Last Updated
2025-07-03
Healthy Volunteers
No
Conditions
Interventions
Ultra-low dose chest CT
A novel CT technique with a new dose optimization and efficiency technology and automatic kV selection, which greatly reduces the dose of radiation exposure compared to a standard chest CT.
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States